AzTrials
AzTrials

Early Intervention in Remote AutismIPAADNCT04660669

Early Intervention in Remote Autism (IPAAD)

A study testing ESDM intervention and MOOC in people with Early Intervention in Remote Autism, run by University Hospital, Brest at 4 sites in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The Early Start Denver Model (ESDM) has shown its efficiency in the early management of ASD. The study aims to evaluate the efficiency of a new type of management based on a semi-intensive center-based intervention (8h per week) coupled with a MOOC (Massive Online Open Course: a teaching and learning intervention… Read more about this study

Who is it for?
Ages 15 to 36 months
Conditions the study is for
Early Intervention in Remote Autism
What is being tested?
ESDM intervention and MOOC
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
4 sitesFrance
Study dates
Dec 2026to Dec 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 36 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Diagnosis of ASD based on the Diagnosis and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria;
  • Diagnosis of ASD on the Autism Diagnosis Observation Schedule (ADOS-2) and Autism Diagnosis Interview (ADIR) for toddlers (we will include children above or equal to 13, which is the research cut-off);
  • Aged between 15 and 36 months;
  • DQ of 30 or above at the MSEL
  • Sign informed consent form by both parents

Who cannot join

  • A neurodevelopmental disorder with known etiology (e.g. fragile X syndrome, Rett syndrom)
  • Significant sensory or motor impairment
  • Major physical problems such as a chronic serious health condition
  • History of a serious head injury and/or neurologic disease
  • Seizures at time of entry
  • Use of psychoactive medications (7 ) Families unavailable for the intervention and the followup over a period of 12 months
  • Impossibility for family to have access to the MOOC

Trial locations and contacts

4 sites in 1 country. Contact the study team or a site near you to ask about taking part.

France4 sites
  • CH Réné-Dubos

    Cergy-Pontoise

    Erwan VION, 01 30 75 48 30, erwan.vion@ght-novo.fr

  • CHU Le Havre

    Le Havre

    Karine LEYDIER, 02 32 73 38 37, karine.leydier@ch-havre.fr

  • CH Limoges

    Limoges

  • CHU Nantes

    Nantes, France

    Françoise DUPONT, 02 28 08 84 90, francoise.dupont@chu-nantes.fr

Other trials in France

About this study

Official title: Early Remote Intervention in Autism: a Randomized Noninferiority Clinical Trial Comparing Semi-intensive Early Start Denver Model (ESDM) Intervention With Remote Parental Training/ Supervision Versus Intensive ESDM Intervention.

The Early Start Denver Model (ESDM) has shown its efficiency in the early management of ASD.

The study aims to evaluate the efficiency of a new type of management based on a semi-intensive center-based intervention (8h per week) coupled with a MOOC (Massive Online Open Course: a teaching and learning intervention based on instrumental and interactive teaching situations) for remote parental training/supervision. The goal is to determine if compared to the ESDM reference intervention (15h per week), this type of care can bring, a sufficient improvement in child development course and decreased symptoms of autism in young children, and if it could be, therefore, better suited to the needs of children and their family, bypassing the previously stated obstacles.

Being tested
ESDM intervention, MOOC
Keywords
Autism, ASD, ESDM, MOOC
Medical subject headings
Autistic Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ESDM interventionOther

    Early Start Denver Model (ESDM) intervention with remote parental training/ supervision versus intensive ESDM intervention.

  • MOOCOther

    Massive Online Open Course: a teaching and learning intervention based on instrumental and interactive teaching situations

Study groups in NCT04660669
Study groupRoleWhat they receive
ESDM 15hOtherThis arm receives 15 hours per week of ESDM intervention from ESDM therapists. The parents benefit from a 20 hour parent training program delivered in the participating center.
Receives: Other: ESDM intervention
ESDM 8h + MOOCOtherThis arm receives 8 hours per week of ESDM intervention from ESDM therapists in addition to whatever community service the parents choose. The parents benefit from a training program remotely delivered via a MOOC platform as well as parental supervision of sessions delivered at home 1 hour per week for the duration of the study.
Receives: Other: ESDM intervention; Other: MOOC

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The gain in developmental quotient measured using the Mullen Scales of Early Learning (MSEL)

    Minimum = 49 (worse outcome) and maximum = 155 (better outcome)

    Measured: From day 0 to months 12

Secondary outcomes (4)
  1. Assessment of child autism symptoms and change in autism symptoms using ADOS-2

    Minimum = 0 (better outcome) and maximum = 28 (worse outcome)

    Measured: At baseline, 6 months after the set up of the intervention and at 12 months after the set up of the intervention

  2. Assessment of child behavioral adaptation using The Vineland Adaptive Behavior Scales second version (VABS-2)

    Minimum = 20 (worse outcome) and maximum = 160 (better outcome)

    Measured: At baseline, 6 months after the set up of the intervention and at 12 months after the set up of the intervention

  3. Assessment of sensory reactivity using The Dunn's Sensory Profile for toddlers

    Minimum = 38 (worse outcome) and maximum = 190 (better outcome)

    Measured: At baseline, 6 months after the set up of the intervention and at 12 months after the set up of the intervention

  4. Assessment of the parent burden and quality of life using the CareQuol-7D

    Minimum = 0 (worse outcome) and maximum = 100 (better outcome)

    Measured: At baseline, 6 months after the set up of the intervention and at 12 months after the set up of the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Dec 2020
  2. Study startDec 2026 (estimated)
  3. Primary completionDec 2027 (estimated)
  4. Study completionDec 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Group 1 receives 15 hours per week of ESDM intervention from ESDM therapists. The parents benefit from a 20 hour parent training program delivered in the participating center. Group 2 receives 8 hours per week of ESDM intervention from ESDM therapists in addition to whatever community service the parents choose. The parents benefit from a training program remotely delivered via a MOOC platform as well as parental supervision of sessions delivered at home 1 hour per week for the duration of the study.
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04660669
Sponsor's protocol ID
IPAAD (29BRC19.0279)
Acronym
IPAAD
Status last verified
Jun 2026
First submitted
9 Nov 2020
Last updated
8 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing ESDM intervention and MOOC in people with Early Intervention in Remote Autism, run by University Hospital, Brest at 4 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 8 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nathalie LAVENNE, Doctor (02 98 01 50 47, nathalie.lavenne-collot@chu-brest.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The gain in developmental quotient measured using the Mullen Scales of Early Learning (MSEL) (time frame: From day 0 to months 12). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in